4/11/2008 10:14:05 AM
ANN ARBOR, Mich., April 11, 2008 (PRIME NEWSWIRE) -- MIR Preclinical Services (MIR) has expanded its range of service offerings to include studies of inflammation and inflammatory pathways. These include in vivo models of inflammation and autoimmune diseases, as well as complementary in vitro and ex vivo work. The Company will also offer custom model development and services to meet client's specific needs. Inflammation is an aspect of many diseases and disorders. MIR views this as an opportunity to provide additional service to pharmaceutical and biotechnology companies in search of advanced therapeutics for these conditions.
comments powered by